Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $5.56M | $36.9M | $1.10B | $1.07B | $1.12B | $1.41B | $1.67B | $1.88B | $2.09B |
| Revenue growth | — | — | 562.5% | 2882.0% | -2.7% | 5.1% | 25.6% | 18.2% | 12.9% | 11.2% |
| Operating income | -$4.96M | — | — | $221M | $218M | $213M | $302M | $307M | $364M | $415M |
| Operating margin | — | — | — | 20.1% | 20.4% | 19.0% | 21.4% | 18.4% | 19.3% | 19.8% |
| Net income | -$5.47M | $541K | -$8.35M | -$4.96M | $2.16M | -$47.8M | -$81.3M | -$71.5M | -$37.8M | $69.8M |
| Net margin | — | 9.7% | -22.7% | -0.5% | 0.2% | -4.3% | -5.8% | -4.3% | -2.0% | 3.3% |
| EPS (diluted) | -$1.75 | $0.02 | -$0.15 | -$0.03 | $0.05 | -$0.95 | -$1.24 | -$1.08 | -$0.29 | $0.42 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.62M | $12.4M | $15.4M | $117M | $219M | $17.9M | $148M | $98.5M | $176M | $294M |
| Share buybacks | $0.00 | $735K | $3.31M | $89.9M | $23.1M | $382K | $20.7M | $469K | $14.0K | $0.00 |
| Dividends paid | $549K | $6.40M | $14.0M | $62.6M | $27.0M | $22.8M | $51.1M | $76.3M | $121M | $164M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.24M | $7.09M | $35.1M | $53.1M | $113M | $81.6M | $65.1M | $43.4M | $76.7M | $115M |
| Total assets | $143M | $480M | $896M | $1.07B | $3.23B | $4.58B | $4.79B | $4.58B | $4.49B | $5.43B |
| Total liabilities | $50.5M | $126M | $337M | $477M | $2.16B | $2.75B | $3.14B | $3.12B | $2.18B | $2.07B |
| Shareholders' equity | $92.3M | $353M | $1.22B | $590M | $866M | $1.58B | $1.40B | $1.27B | $2.26B | $3.32B |
| Retained earnings | -$7.35M | -$23.5M | -$64.8M | -$131M | -$864M | -$951M | -$1.14B | -$1.28B | -$1.46B | -$1.56B |
| Shares (wtd avg diluted) | — | — | — | 182M | 45.0M | 50.1M | 65.8M | 66.0M | 131M | 167M |
Every figure is extracted from American Healthcare REIT, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.